Drugmaker AbbVie Inc. filed a lawsuit Thursday against Thousand Oaks biotech Amgen Inc. claiming patent infringement of its top-selling drug Humira, which brought in $14 billion in revenue in 2015...

Subscribe to get the full story.


Are you a subscriber? Sign In